1. HBW Insight
  2. >>Leadership

US FDA Staff’s Union President Calls For More Support From Industry

 
• By Sarah Karlin-Smith

Industry should be more vocal about the harms the recent reduction-in-force will have on getting drugs to market, NTEU Chapter 282 President Anthony Lee said in an interview with Pink Sheet.

orange paper that reads "speak up!"
The chapter president of a union that represents FDA employees wants industry to speak up about the impacts of recent layoffs. (Shutterstock)
Key Takeaways
  • The chapter president of the union that represents FDA staff is calling on industry to be more vocal about the harms resulting from the 3,500-person reduction-in-force implemented on 1 April.
  • The union has filed an institutional grievance over the RIFs, which it says were done in violation of the HHS-union labor agreement.
  • The union is also urging RIFed staff not to voluntarily agree to work while on administrative leave.

The industries that the US Food and Drug Administration regulates should be more vocal in calling out the harms of mass layoffs that took place on 1 April, the chapter president of the

“The industry, for the most part, has been silent on what is going on here, and they are definitely going to be impacted by a [reduction-in-force] of 3,500 people,” National Treasury Employees

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

In Blistering Criticism, Health Subcommittee Democrat Warns Of Kennedy’s ‘Toxic Brew’ Plans

 
• By Malcolm Spicer

Trump’s first-term public health appointees “were serious people doing serious work in a bipartisan nature,” but HHS Secretary Robert F. Kennedy and other current presidential advisors “are not serious people,” says Massachusetts’ Jake Auchincloss.

MAHA Translates To ‘Change The Broken System’ At US FDA For Commissioner Makary

 
• By Malcolm Spicer

Among FDA's diversions from accepted practices is not going “through the bureaucracy” of advisory committees for experts’ input on potential changes to improve the safety and nutrition profile of food products, says Commissioner Martin Makary.

Commissioner Makary Outlines Expectations For US FDA: ‘Challenge Deeply Held Assumptions’

 
• By Malcolm Spicer

“It was a little hard to begin after the change or the reduction in force. We're doing everything we can to do an assessment, restore some services of individuals, and also try to rebuild the culture, because it is a great culture,” says FDA Commissioner Martin Makary during FDLI conference.

US FDA Restoring Some Library Resources

 
• By Sue Sutter and Derrick Gingery

Agency staff once again have access to the Lexis-Nexis legal and news database, but are still waiting for access to journals, and laid off librarians have not been reinstated.

More from HBW Insight

US FDA Expands Surprise Foreign Inspections

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.

Commissioner Makary Outlines Expectations For US FDA: ‘Challenge Deeply Held Assumptions’

 
• By Malcolm Spicer

“It was a little hard to begin after the change or the reduction in force. We're doing everything we can to do an assessment, restore some services of individuals, and also try to rebuild the culture, because it is a great culture,” says FDA Commissioner Martin Makary during FDLI conference.

‘Made In The USA’ Claims May Be Popular In Time Of Tariffs, But Mistakes Are Costly – NAD

 
• By Eileen Francis

The National Advertising Division expects cases involving ‘Made in the USA’ claims to increase given US tariffs, says NAD VP Phyllis Marcus. The topic was also addressed by BBB National Programs’ Mary Engle during IBA’s Cosmetics Convergence Virtual Spring Conference 14-15 May.